Nhà máy Stada
Antihistamines & Antiallergics



Pack size:

Box of 10 blisters x 10 tablets.



Each tablet contains loratadin 10 mg.



36 months from the date of manufacturing.

Store in a well-closed container, in a dry place. Do not store above 30oC.


  • Indications and Dosage & Administration
  • Contraindications
  • Adverse reactions
  • Precautions

  • The symptomatic relief of allergic conditions including rhinitis and chronic urticaria.
  • Only administered orally. 
  • Adult and children ≥ 12 years: 10 mg once daily.
    Children 2 - 12 years: 
    Body-weight over 30 kg: 10 mg once daily.
    Body-weight under 30 kg: 5 mg once daily.

Or as advised by physicians.

  • Patients who have shown hypersensitivity or idiosyncrasy to any ingredient of the drug.
  • Children under  2 years old.


  • Serious ventricular arrhythmias, as reported with some other second-generation histamine H1-receptor antagonists, have not been observed with loratadine.
  • When use loratadine with dosage more than 10 mg daily, following adverse and side effects may occur:


  • Headache.
  • Dry mouth.

Less common

  • Vertigo.
  • Nasal dryness and sneezing.
  • Conjunctivitis.


  • Depression.
  • Tachycardia, supraventricular tachyarrhythmias, palpitations.
  • Nausea.
  • Abnormal hepatic function, menstrual rhythm alteration.
  • Exanthema, urticaria, and anaphylaxis.


  • Impairment liver.
  • There is risk of dry mouth, especially in elderly, with increased risk of caries. Especially, careful mouth and dental hygiene is therefore needed.
  • Pregnancy: Safe use of loratadine products during pregnancy has not been established, therefore, use only if potential benefit justifies potential risk to fetus.
  • Lactation: Since loratadine is excreted in breast milk and because of the increased risk of antihistamines for infants, particularly newborns and premature infants, a decision should be made whether to discontinue nursing or discontinue the drug.
  • Effects on ability to drive and use machines: In clinical trials that assessed driving ability, no impairment occurred in patients receiving loratadine. However, patients should be informed that very rarely some people experience drowsiness, which may affect their ability to drive or use machines.


Contact us

FACTORY 1: K63/1 Nguyen Thi Soc St., Xuan Thoi Dong, Hoc Mon, HCMC
Tel: +84 28 3718 2141 - Fax: +84 28 3718 2140

FACTORY 2: 40 Tu Do Avenue, VietNam-Singapore Industrial Park, Binh Duong
Tel: +84 274 376 7470 - Fax: +84 274 376 7469
Email : stada@stada.com.vn
Website: www.stada.com.vn

Visitors Counter